Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - The page revision tag was updated from v3.4.2 to v3.4.3. This is a minor metadata update and does not affect the page's content or functionality.
    Difference
    0.1%
    Check dated 2026-03-11T16:36:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. The funding-status notices from earlier versions (lapse in government funding and related operating-status details) have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T06:24:30.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a government funding notice banner about potential delays and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:52:27.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata related to QC status and policy (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed or changed the previous QC label and revision reference (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T02:55:21.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaced v3.3.3 on the page. This appears to be a minor update with no changes to study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-01-14T03:11:47.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Introduces a Locations section with state locations (Arizona, California, Georgia, Indiana, Massachusetts, New Jersey, Ohio) and updates the revision to v3.3.3. Individual state location subsections and the HHS Vulnerability Disclosure text were removed.
    Difference
    0.9%
    Check dated 2025-12-23T20:33:36.000Z thumbnail image

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.